To achieve satisfying results, you may need more sessions or try different non-surgical treatments (like Fat Freezing)
Patel E, Jones Iii JP 3rd, Bono-Lunn D, Kuchibhatla M, Palkar A, Cendejas Hernandez J, et al
J., Cavender, M
The results suggested that TB-500 not only potentially enhanced the viability, angiogenesis, and migratory ability of HUVEC but possibly also promoted the expression of angiopoietin-2 (Ang2), TEK receptor tyrosine kinase 2 (tie2), vascular endothelial growth factor A (VEGFA), NOTCH1 intracellular domain (N1ICD), Notch receptor 3 (Notch3), NF-B, and phosphorylated (p)-p65 in HUVEC
Standard dose: 0.3ml daily subcutaneous injection Advanced dose: 0.5ml daily for intensive protocols Frequency: Once daily, preferably at consistent time Duration: 8-12 week cycles with 4-6 week breaks Injection location can vary
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases